Coliform bacteria are indicators of water quality; however, most detection methods for coliform bacteria are time-consuming and nonspecific. Here, we developed a fluorescence in situ hybridization (FISH) approach to detect four types of coliform bacteria, including Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, and Citrobacter freundii, simultaneously in water samples using specific probes for 16S rRNA. This FISH method was applied to detect coliform bacteria in simulated water and domestic wastewater samples and compared with traditional detection methods (e.g., plate counting, multiple-tube fermentation (MTF) technique, and membrane filter (MF) technique). Optimal FISH conditions for detecting the four types of coliforms were found to be fixation in 3% paraformaldehyde at 4 °C for 2 h and hybridization at 50 °C for 1.5 h. By comparing FISH with plate counting, MTF, MF, and a commercial detection kit, we found that FISH had the shortest detection time and highest accuracy for the identification of coliform bacteria in simulated water and domestic wastewater samples. Moreover, the developed method could simultaneously detect individual species and concentrations of coliform bacteria. Overall, our findings indicated that FISH could be used as a rapid, accurate biosensor system for simultaneously detecting four types of coliform bacteria to ensure water safety.

Blood reflux and metabolic regulation play important roles in chronic venous disease (CVD) development. Histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) serve as repressors that inhibit metabolic signaling, which is induced by proatherogenic flow to promote aortic endothelial cell (EC) dysfunction and atherosclerosis. The aim of this study was to elucidate the relationship between blood reflux and epigenetic factors HDACs and DNMTs in CVD. Human varicose veins with different levels of blood reflux versus normal veins with normal venous flow were examined. The results show that HDAC-1, -2, -3, -5, and -7 are overexpressed in the endothelium of varicose veins with blood reflux. Blood reflux-induced HDACs are enhanced in the varicose veins with a longer duration time of blood reflux. In contrast, these HDACs are rarely expressed in the endothelium of the normal vein with normal venous flow. Similar results are obtained for DNMT1 and DNMT3a. Our findings suggest that the epigenetic factors, HDACs and DNMTs, are induced in venous ECs in response to blood reflux but are inhibited in response to normal venous flow. Blood reflux-induced HDACs and DNMTs could inhibit metabolic regulation and promote venous EC dysfunction, which is highly correlated with CVD pathogenesis.

Background. MicroRNA-10a (miR-10a) inhibits transcriptional factor GATA6 to repress inflammatory GATA6/VCAM-1 signaling, which is regulated by blood flow to affect endothelial function/dysfunction. This study aimed to identify the expression patterns of miR-10a/GATA6/VCAM-1 in vivo and study their implications in the pathophysiology of human coronary artery disease (CAD), i.e., atherosclerosis. Methods. Human atherosclerotic coronary arteries and nondiseased arteries were used to detect the expressions of miR-10a/GATA6/VCAM-1 in pathogenic vs. normal conditions. In addition, sera from CAD patients and healthy subjects were collected to detect the level of circulating miR-10a. Results. The comparison of human atherosclerotic coronary arteries with nondiseased arteries demonstrated that lower levels of endothelial miR-10a are related to human atherogenesis. Moreover, GATA6/VCAM-1 (a downstream target of miR-10a) was highly expressed in the endothelium, accompanied by the reduced levels of miR-10a during the development of human atherosclerosis. In addition, CAD patients had a significantly lower concentration of miR-10a in their serum compared to healthy subjects. Conclusions. Our findings suggest that low miR-10a and high GATA6/VCAM-1 in the cardiovascular endothelium correlates to the development of human atherosclerotic lesions, suggesting that miR-10a signaling has the potential to be developed as a biomarker for human atherosclerosis.

Au and Ag nanoparticles (NPs) exhibit distinct pharmacological activities, cytotoxicity profiles, and catalytic properties. This study sought to maximize the advantages of both metals while reducing the production of toxic byproducts and promoting the rapid synthesis of Au-Ag alloy NPs. For this, we used Melaleuca quinquenervia leaf extract (MQLE) as a reducing and capping agent alongside microwave-assisted green synthesis techniques. The physicochemical properties and biological activities of the synthesized Au-Ag alloy NPs were systematically evaluated. Our findings confirmed successful synthesis of nearly spherical Au-Ag alloy NPs with an average diameter of 37 nm, achieved within a 60 s irradiation period. Energy-dispersive spectroscopy (EDS) revealed a nearly uniform elemental composition, with Au and Ag constituting 43.56% and 40.21%, respectively, of the alloy. Thermogravimetric (TG) analysis confirmed the complete coating of the NPs with MQLE. Owing to these characteristics, the Au-Ag alloy NPs exhibited low cytotoxicity (half-maximal inhibitory concentration [IC₅₀] > 110 mg/L), strong antioxidant activity (IC₅₀ < 15 mg/L), reasonable antimicrobial efficacy (minimum inhibitory concentration: 2.5–10 mg/L), considerable anti-inflammatory potential (IC₅₀: 9.45–35.41 mg/L), promising wound healing capacity (72.5% in 24 h), and excellent catalytic performance (apparent rate constant: 0.254–0.654 min⁻¹). In conclusion, the rapid, efficient, and environmentally friendly synthesis of Au-Ag alloy NPs demonstrated in this study holds promise for various industrial applications, particularly in pharmaceutical and therapeutic development.